bmiMD vs Hims: Which GLP-1 Provider Is Better?
Short answer: bmiMD scores higher on our rubric, 8.0/10 against 7.9/10. Full reasoning, pricing and the cases where the other one wins are below.
bmiMD beats Hims overall, scoring 8/10 vs 7.9/10. Published pricing is not a like-for-like monthly comparison: bmiMD is $289/mo month-to-month; Hims is $188 first month, then $298/mo. Choose bmiMD for users who want an established, large-scale platform with same-day consults and strong promo pricing. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.
A side-by-side look at bmiMD and Hims to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
bmiMD
#4 of 54Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDHims
#7 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit Hims| Feature | bmiMD | Hims |
|---|---|---|
| Why each one | One of the largest GLP-1 telehealth platforms (80,000+ customers) with same-day physician consults and a money-back eligibility guarantee. | The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers. |
| Our Score | 8/10 | 7.9/10 |
| Headline Price | $289/mo month-to-month | $188 first month, then $298/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | No |
| Best For | Users who want an established, large-scale platform with same-day consults and strong promo pricing | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors |
| Watch out for | Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. |
| Ranking | #4 | #7 |
| Get started | Visit bmiMD | Visit Hims |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with a 4.3-star Trustpilot rating (600+ reviews) provides real social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
- −$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
- −A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Our Verdict
bmiMD edges out Hims with a score of 8/10 vs 7.9/10. Published pricing is not a like-for-like monthly comparison: bmiMD is $289/mo month-to-month; Hims is $188 first month, then $298/mo. bmiMD offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving bmiMD and Hims.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- bmiMD vs WeightWatchers (Sequence)$74/mo membership + medication
- bmiMD vs Calibratepublished $199/mo; total not verified
- bmiMD vs Hers$188 first month, then $298/mo
- Hims vs Yucca Healthfrom $146/mo
- Hims vs Wellorithmfrom $147/mo
- Hims vs SkinnyRxfrom $199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: bmiMD · 8.0/10